tiprankstipranks
Alnylam Pharmaceuticals (GB:0HD2)
LSE:0HD2
UK Market

Alnylam Pharma (0HD2) Technical Analysis

4 Followers

Technical Sentiment

Overall Consensus
Strong Sell
0Bullish
0Neutral
13Bearish
Technical Analysis Consensus
Strong Sell
0Bullish
0Neutral
1Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Alnylam Pharmaceuticals’s (0HD2) Moving Averages Convergence Divergence (MACD) indicator is -7.54, suggesting Alnylam Pharmaceuticals is a Buy.
Alnylam Pharmaceuticals’s (0HD2) 20-Day exponential moving average is 269.98, while Alnylam Pharmaceuticals’s (0HD2) share price is $285.82, making it a Sell.
Alnylam Pharmaceuticals’s (0HD2) 50-Day exponential moving average is 285.55, while Alnylam Pharmaceuticals’s (0HD2) share price is $285.82, making it a Sell.

Alnylam Pharma (0HD2) Pivot Points

Aug 02, 2026, 08:23 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
Fibonacci
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Alnylam Pharma (0HD2) Moving Averages

Aug 02, 2026, 08:23 PM
Period
Simple
Exponential
MA5
251.50Sell
237.32Sell
MA10
261.21Sell
254.92Sell
MA20
279.86Sell
269.98Sell
MA50
288.29Sell
285.55Sell
MA100
299.78Sell
303.58Sell
MA200
348.17Sell
348.74Sell
Alnylam Pharmaceuticals’s (0HD2) 10-Day exponential moving average is 254.92, while Alnylam Pharmaceuticals’s (0HD2) share price is $285.82, making it a Sell.
Alnylam Pharmaceuticals’s (0HD2) 100-Day exponential moving average is 303.58, while Alnylam Pharmaceuticals’s (0HD2) share price is $285.82, making it a Sell.
Alnylam Pharmaceuticals’s (0HD2) stock price is $285.82 and Alnylam Pharmaceuticals’s (0HD2) 50-day simple moving average is 288.29, creating a Sell signal.
Alnylam Pharmaceuticals’s (0HD2) stock price is $285.82 and Alnylam Pharmaceuticals’s (0HD2) 100-day simple moving average is 299.78, creating a Sell signal.
Alnylam Pharmaceuticals’s (0HD2) stock price is $285.82 and Alnylam Pharmaceuticals’s (0HD2) 200-day simple moving average is 348.17, creating a Sell signal.

Alnylam Pharma (0HD2) Technical Indicators

Aug 02, 2026, 08:23 PM
Name
Value
Implied Action
RSI (14)
39.34
Neutral
STOCH (9,6)
20.48
Neutral
STOCHRSI (14)
5.76
Buy
MACD (12,26)
-7.54
Buy
ADX (14)
17.77
Buy
Williams %R
-91.49
Buy
CCI (14)
-84.13
Neutral
ATR (14)
15.09
-
Ultimate Oscillator
42.51
Neutral
ROC
-29.37
Sell
Alnylam Pharmaceuticals’s (0HD2) Relative Strength Index (RSI) is 39.34, creating a Neutral signal.
Alnylam Pharmaceuticals’s (0HD2) Trend Strength Indicator (ADX) is 17.77, creating a Buy signal.
Alnylam Pharmaceuticals’s (0HD2) Commodity Channel Index (CCI) is -84.13, creating a Neutral signal.
Alnylam Pharmaceuticals’s (0HD2) Price Rate of Change (ROC) is -29.37, creating a Sell signal.

FAQ

Is 0HD2 a Buy, Hold, or Sell?
Based on 0HD2’s technical indicators, 0HD2 is a Strong Sell.
    What is 0HD2’s RSI (14)?
    0HD2’s RSI (14) is 39.34, which suggests 0HD2 is a Neutral.
      What is 0HD2’s MACD?
      0HD2’s MACD is -7.54, which suggests 0HD2 is a Buy.
        What is 0HD2’s 5-day moving average?
        0HD2’s 5-day moving average is 251.50, which suggests 0HD2 is a Sell.
          What is 0HD2’s 20-day moving average?
          0HD2 20-day moving average is 279.86, which suggests 0HD2 is a Sell.
            What is 0HD2’s 50-day moving average?
            0HD2’s 50-day moving average is 288.29, which suggests 0HD2 is a Sell.
              What is 0HD2’s 200-day moving average?
              0HD2’s 200-day moving average is 348.17, which suggests 0HD2 is a Sell.
                What is 0HD2’s Williams % R (14)?
                0HD2’s Williams % R (14) is -91.49, which suggests 0HD2 is a Buy.
                  What is 0HD2’s CCI (14)?
                  0HD2’s CCI (14) is -84.13, which suggests 0HD2 is a Neutral.
                    What is the share price of Alnylam Pharmaceuticals?